RESUMO
Introduction: COVID‑19 is caused due to infection with severe acute respiratory syndrome‑coronavirus‑2. A change in the epidemiological pattern of neurovascular diseases has been observed among patients who have had COVID‑19 infection. There are not enough studies which have evaluated the neurovascular manifestations among patients of COVID‑19 infection. MaterialsandMethods: This single‑center observational study was intended to evaluate the correlation between various COVID‑19‑related parameters with the outcomes of vascular events among patients of COVID‑19 who developed neurovascular complications. The study was conducted at a tertiary hospital in Pune, India, from February 01, 2021, to October 10, 2021. The study population involved patients with COVID‑19 of varying severity and associated neurovascular complications. The total number of patients was 22 in number. The deidentified data were analyzed using JMP version 10.040. Results: Among a total of 22 patients, 16 (73%) had arterial infarcts, 5 (23%) had venous infarcts, whereas 1 (4%) had intracerebral hemorrhage. Four (18%) patients had features of severe COVID‑19 and 2 (9%) of them had a modified Rankin Scale of six. There was a strong correlation between the severity of COVID infection and the severity of neurovascular complications. A positive correlation was observed between the time duration from Reverse transcriptase polymerase chain reaction (RT‑PCR) positivity to neurovascular complications with the duration of >45 days having a poorer outcome. Conclusion: COVID‑19 is more likely to cause thrombotic vascular events including stroke. The severity of COVID‑19 is directly correlated with poorer outcomes. The duration between RT‑PCR positivity and neurovascular symptoms if >45 days, has a poorer outcome